ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
Language English Country United States Media print-electronic
Document type Journal Article, Practice Guideline, Research Support, Non-U.S. Gov't
PubMed
33397713
DOI
10.1136/ijgc-2020-002230
PII: S1048-891X(24)02602-1
Knihovny.cz E-resources
- Keywords
- pathology, radiation, surgery, uterine cancer,
- MeSH
- Medical Oncology standards MeSH
- Humans MeSH
- Endometrial Neoplasms diagnosis pathology therapy MeSH
- Genital Neoplasms, Female diagnosis therapy MeSH
- Preoperative Care MeSH
- Risk Factors MeSH
- Check Tag
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Practice Guideline MeSH
- Geographicals
- Europe MeSH
A European consensus conference on endometrial carcinoma was held in 2014 to produce multi-disciplinary evidence-based guidelines on selected questions. Given the large body of literature on the management of endometrial carcinoma published since 2014, the European Society of Gynaecological Oncology (ESGO), the European SocieTy for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) jointly decided to update these evidence-based guidelines and to cover new topics in order to improve the quality of care for women with endometrial carcinoma across Europe and worldwide.
Clinical Research Unit Institut Bergonie Bordeaux France
Department of Gynaecologic Oncology Imperial College London Faculty of Medicine London UK
Department of Gynaecology Royal Marsden Hospital London UK
Department of Gynecology and Obstetrics Innsbruck Medical University Innsbruck Austria
Department of Medical Oncology Clinica Universidad de Navarra Madrid Spain
Department of Medical Oncology St James Hospital Dublin Ireland
Department of Obstetrics and Gynecologic Oncology University Hospital Strasbourg France
Department of Obstetrics and Gynecology Innsbruck Medical University Innsbruck Austria
Department of Oncology Rigshospitalet Copenhagen University Hospital Copenhagen Denmark
Department of Pathology Hospital Graz 2 Graz Austria
Department of Pathology Hospital Universitari de Bellvitge University of Barcelona Idibell Spain
Department of Pathology Leids Universitair Medisch Centrum Leiden Netherlands
Department of Radiation Oncology Institut Gustave Roussy Villejuif France
Department of Radiation Oncology Leiden University Medical Center Leiden Netherlands
Department of Radiation Oncology Medical Faculty of the University of Cologne Cologne Germany
Department of Radiotherapy Erasmus MC Cancer Institute Rotterdam Netherlands
Department of Surgery Institut Gustave Roussy Villejuif France
Division of Gynecologic Oncology Fondazione Policlinico Universitario A Gemelli IRCCS Rome Italy
Evangelische Kliniken Essen Mitte Essen Germany
Histopathology and Molecular Diagnostics Azienda Ospedaliero Universitaria Careggi Florence Italy
School of Medicine Johannes Kepler University Linz Linz Austria
References provided by Crossref.org
Preoperative CA125 Significantly Improves Risk Stratification in High-Grade Endometrial Cancer
Relevance of Molecular Profiling in Patients With Low-Grade Endometrial Cancer
External validation study of endometrial cancer preoperative risk stratification model (ENDORISK)
Does an Endometrial Cancer Diagnosis among Asymptomatic Patients Improve Prognosis?
New Trends in the Detection of Gynecological Precancerous Lesions and Early-Stage Cancers
Tumor Characteristic Variations between Symptomatic and Asymptomatic Endometrial Cancer
